InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Cardama Alfonso Quintas, Dirigeant. Director active across 1 companies, notably TCR2 THERAPEUTICS INC.. In total, 2 reports have been recorded. The latest transaction was filed on 31 August 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€1,980164 shares@ €12.0742100.0% of flow
Common Stock
SEC:0001209191-21-069055·
€1,980164 shares@ €12.074250.0% of flow
Common Stock
SEC:0001209191-21-069055:0·
2 of 2 declarations
About Cardama Alfonso Quintas
Alfonso Quintas Cardama is the Chief Medical Officer at TCR2 Therapeutics Inc. He oversees the company's medical and scientific initiatives, contributing to innovation in the field of cell therapies. His expertise is crucial for the development of innovative treatments for serious diseases.
